Skip to main content

T-cell response after third SARS-CoV-2 vaccination in patients with MS on ocrelizumab

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
T-cell response after third SARS-CoV-2 vaccination in patients with MS on ocrelizumab

User login

Username

Password

Reset your password

Type	Lead	score